In our study conducted in two NSCLC cells, we found that silencing of HOXD9 induces the G1 phase arrest, as well as reduced the expression of G1/S-specific cyclin E and G2/M-specific cyclin B1. This evidence concerns the gene HOXD9 and non-small cell lung carcinoma.